Elderly women: Homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism)

Nutrition

Volumn 29, Issue 6, 2013, Pages 841-844

  Chmurzynska, Agata ^a   Malinowska, Anna M ^a   Twardowska Rajewska, Jolanta ^b   Gawecki, Jan ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Elderly; Folic acid supplementation; Homocysteine; Lipids; MTHFR

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; POLISH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SHORT COURSE THERAPY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ALLELES; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; LIPID METABOLISM; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUESTIONNAIRES; WAIST-HIP RATIO;

EID: 84877591242     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.09.015     Document Type: Article

References (35)

1. Bailey L.B., Gregory J.F. Folate metabolism and requirements. J Nutr 1999, 129:779-782.
2. Malinowska A., Chmurzynska A. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease. Nutr Res 2009, 29:685-695.
3. Souto J.C., Blanco-Vaca F., Soria J.M., Buil A., Almasy L., Ordonez-Llanos J., et al. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 2005, 76:925-933.
4. Vermeulen S.H., van der Vleuten G.M., de Graaf J., Hermus A.R., Blom H.J., Stalenhoef A.F., et al. A genome-wide linkage scan for homocysteine levels suggests three regions of interest. J Thromb Haemost 2006, 4:1303-1307.
5. Husemoen L.L., Thomsen T.F., Fenger M., Jørgensen H.L., Jørgensen T. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99(2). Genet Epidemiol 2003, 24:322-330.
6. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
7. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288:2023-2031. MTHFR Studies Collaboration Group.
8. Spotila L.D., Jacques P.F., Berger P.B., Ballman K.V., Ellison R.C., Rozen R. Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level. Am J Epidemiol 2003, 158:871-877.
9. De Bree A., Verschuren W.M., Kromhout D., Kluijtmans L.A., Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002, 54:599-618.
10. Refsum H., Nurk E., Smith A.D., Ueland P.M., Gjesdal C.G., Bjelland I., et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006, 136(6 suppl):1731S-1740S.
11. Konstantinova S.V., Vollset S.E., Berstad P., Ueland P.M., Drevon C.A., Refsum H., et al. Dietary predictors of plasma total homocysteine in the Hordaland Homocysteine Study. Br J Nutr 2007, 98:201-210.
12. Berstad P., Konstantinova S.V., Refsum H., Nurk E., Vollset S.E., Tell G.S., et al. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am J Clin Nutr 2007, 85:1598-1605.
13. Obeid R., Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009, 583:1215-1225.
14. Chapman M.J., Ginsberg H.N., Amarenco P., Andreotti F., Borén J., Catapano A.L., et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011, 32:1345-1361. European Atherosclerosis Society Consensus Panel.
15. Luc G., Jacob N., Bouly M., Fruchart J.C., Staels B., Giral P. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism. J Cardiovasc Pharmacol 2004, 43:452-453.
16. Yideng J., Zhihong L., Jiantuan X., Jun C., Guizhong L., Shuren W. Homocysteine-mediated PPAR alpha, gamma DNA methylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol 2008, 27:143-150.
17. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006, 151:282-287. B-Vitamin Treatment Trialists' Collaboration.
18. Clarke R., Halsey J., Lewington S., Lonn E., Armitage J., Manson J.E., et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010, 170:1622-1631. B-Vitamin Treatment Trialists' Collaboration.
19. Papoutsakis C., Manios Y., Magkos F., Papaconstantinou E., Schulpis K.H., Zampelas A., et al. Effect of the methylenetetrahydrofolate reductase (MTHFR 677C→T) polymorphism on plasma homocysteine concentrations in healthy children is influenced by consumption of folate-fortified foods. Nutrition 2010, 26:969-974.
20. Rydlewicz A., Simpson J.A., Taylor R.J., Bond C.M., Golden M.H. The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM 2002, 95:27-35.
21. Özturk H., Durga J., van de Rest O., Verhoeff P. The MTHFR 677 C→T genotype modifies the relation of folate intake and status with plasma homocysteine in middle-aged and elderly people. Ned Tijdschr Klin Chem Labgeneesk 2005, 30:208-217.
22. van Oort F.V., Melse-Boonstra A., Brouwer I.A., Clarke R., West C.E., Katan M.B., et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J ClinNutr 2003, 77:1318-1323.
23. Anderson C.A., Jee S.H., Charleston J., Narrett M., Appel L.J. Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol 2010, 172:932-941.
24. Pufulete M., Emery P.W., Nelson M., Sanders T.A. Validation of a short food frequency questionnaire to assess folate intake. Br J Nutr 2002, 87:383-390.
25. Głowacki R., Bald E. Determination of N-acetylcysteine and main endogenous thiols in human plasma by HPLC with ultraviolet detection in the form of their S-quinolinium derivatives. J Liq Chrom Rel Techn 2009, 32:2530-2544.
26. Głowacki R., Bald E. Fully automated method for simultaneous determination of total cysteine, cysteinylglycine, glutathione and homocysteine in plasma by HPLC with UV absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:3400-3404.
27. Malinow M.R., Ducimetiere P., Luc G., Evans A.E., Arveiler D., Cambien F., Upson B.M. Plasma homocysteine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis 1996, 126:27-34.
28. Wilcken B., Bamforth F., Li Z., Zhu H., Ritvanen A., Renlund M., et al. Geographical and ethnic variation of the 677C→T allele of 5,10ethylenetetrahydrofolatereductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003, 40:619-625.
29. Goracy I., Cyryłowski L., Kaczmarczyk M., Fabian A., Koziarska D., Goracy J., et al. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects. J Appl Genet 2009, 50:63-67.
30. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005, 82:806-812. Homocysteine Lowering Trialists' Collaboration.
31. Qujeq D., Omran T.S., Hosini L. Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem 2001, 34:97-101.
32. Devlin A.M., Lentz S.R. ApoA-I: a missing link between homocysteine and lipid metabolism?. Circ Res 2006, 98:431-433.
33. Real J.T., Martinez-Hervas S., Garcia-Garcia A.B., Chaves F.J., Civera M., Ascaso J.F., et al. Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia. J Atheroscler Thromb 2009, 16:815-820.
34. Kiseljaković E., Valjevac A., Hasić S., Nakas-Ićindić E., Dzubur A., Jadrić R. Association of homocysteine with traditional and non-traditional risk factors in patients with atherosclerotic vascular disease. Med Glas Ljekkomore Zenicko-doboj kantona 2011, 8:126-133.
35. Lewis S.J., Lawlor D.A., Nordestgaard B.G., Tybjaerg-Hansen A., Ebrahim S., Zacho J., et al. The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts. Eur J Endocrinol 2008, 159:35-40.